To verify that TG2 induced activation of NF-κB and the downregulation of PTEN as observed in TG2 overexpressing MEFtg2-/- is not cell specific and pertinent to TG2 protein, experiments were repeated using MCF-7 and T-47D breast cancer cells. The gene discussed is TGM2; the disease is breast carcinoma.